Gaining Ground: Expanding Options for Advanced HCC - Episode 1

Overview of Hepatocellular Carcinoma Risk Factors

December 22, 2022

Ghassan K. Abou-Alfa, MD, Robert J. Lewandowski, MD, FSIR, Amit Singal, MD, MS

Ghassan Abou-Alfa, MD leads Robert Lewandowski, MD, FSIR, and Amit Singal, MD in a discussion of the main risk factors for hepatocellular carcinoma.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

Now Viewing

EP. 1: Overview of Hepatocellular Carcinoma Risk Factors

EP. 2: Review of Curative Treatment Strategies for HCC

EP. 3: Child-Pugh Scoring System and Liver Function Assessment

EP. 4: Therapy for Locally Advanced HCC

EP. 5: The Advent of Systemic Therapy for HCC

EP. 6: Immune Checkpoint Inhibitors in HCC

EP. 7: Combination Therapy with Immune Checkpoint Inhibitors for HCC

EP. 8: IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCC

EP. 9: Immune Checkpoint Inhibitors and Their Effects on Liver Function

EP. 10: Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial Endpoints

EP. 11: Novel Strategies: Combining Systemic and Local Therapies

EP. 12: HCC International Clinical Trials